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CORRESPONDENCE 
Cancer risk from exposure to 
occupational acrylamide 
Recently the results of a comprehensive 
epidemiological follow up study of cancer 
mortality in cohorts with occupational expo 
sure to acrylamide was published.1 With the 
exception of a weak significance for a raised 
incidence of pancreatic cancer the study 
arrived by and large at the conclusion that 
there is "little evidence for a causal relation 
between exposure to acrylamide and mor 
tality from any cancer sites". The study 
updates and confirms an investigation 10 
years earlier of the same cohorts.2 The analy 
sis was based on standardised mortality ratios 
(SMRs) in comparison with United States 
national or relevant county mortality statis 
tics. It exemplifies the shortcomings of epide 
miological studies of this kind to detect mod 
erate influences of specific causative factors 
on cancer mortality or incidence. The 
investigators state that they have carried out 
"the most definitive study of the human car 
cinogenic potential of exposure to acrylamide 
conducted to date". The results, however, 
pose questions. Could unacceptable risks be 
detected? Which risks would have been 
expected? 
For the workers in the United States the 
average cumulative exposure is given as 0.25 
mg/m3.y. (We assume this to correspond to 
exposure of the whole factory staff to 0.25 
mg/m3 for 365 8 hour working days). At an 
alveolar ventilation rate of 0.2 1/kg.min this 
exposure would mean a cumulative uptake of 
about 9 mg acrylamide per kg body weight. 
This dose corresponds to a lifetime (70 years) 
uptake of 0.35 |ng/kg.d. According to the esti 
mate of the United States Environmental 
Protection Agency3 this would correspond to 
a cancer risk of 1.6xl0'3. An estimate based 
on the multiplicative model4 would arrive at 
roughly a 3 times higher risk, 5xl0"3. With a 
cancer mortality in the western world coun 
tries of 0.18, these figures correspond to a 
l%-3% increase of the cancer mortality risk 
(RR)?that is, an RR of 1.01-1.03. As about 
one fifth of the workers were defined as 
exposed (at^lO-3 mg/m3.y) the relative risk 
in the exposed group due to inhalation of 
acrylamide may have been about 1.05-1.15. 
Although it is doubtful that these risk 
increments could be considered negligible, 
they would not be detectable in a study of the 
present kind. As uptake through the skin 
often occurs in addition to inhalation of acry 
lamide it is possible that the true risk 
increments are considerably higher. If we 
assume the total relative risk (from inhalation 
plus dermal uptake) to be in the range of 
1.1-1.2, it is a pertinent question whether 
this risk increment is detectable within the 
large body of material studied by Marsh et al.1 
Like many other materials of similar kinds 
the data are far from ideal for epidemiological 
analyses. The main reasons for this are the 
skewed distribution of duration of employ 
ment, the incompleteness of data for smok 
ing, and the healthy worker effect. The 
healthy worker effect leads to a deficit in 
death rates from all causes, in the present 
study by about 20% for all causes except can 
cers. Deficits in SMR for all malignant 
neoplasms and for certain tumour types are 
also often significant, although with a disturb 
ing influence of a significantly increased SMR 
for lung cancer in an earlier period. (The sig 
nificant decrease in deaths from lung cancer 
as well as deaths from diseases of the circula 
tory system from 1925-83 to 1984-94 would 
be compatible with a drastic reduction in 
smoking, before 1984.) It is expected that the 
healthy worker effect comprises cancer, at 
least to some extent, as well as other causes of 
death. 
A straightforward way of overcoming the 
healthy worker effect is a within cohort 
analysis of the regression of mortalities or 
incidences on the estimated dose. Marsh et at 
have done this for each of a few selected 
tumour sites. Due to too few observed deaths 
in each dose interval the statistical power of 
this material is, however, too small to show 
anything. 
This analysis of individual sites, avoiding a 
pooling of data that would increase the statis 
tical power, illustrates the widespread dogma 
that different cancer types are affected 
specifically by carcinogens. It has been shown 
for a few mutagenic carcinogens including 
acrylamide that a linear multiplicative model, 
Pj=P?j (1+? D), can be fitted to experimental 
cancer incidence data and, for radiation, to 
human data.5 P- and P? are the total and 
background risks of tumour at site j, D the 
dose and ? a relative risk coefficient that is (at 
least approximately) the same for all tumour 
sites j. ? is thus applicable to pooled data for 
groups of sites or for all (responding) sites. 
Although analysis of death risks associated 
with specific tumours has its indisputable 
value, a restriction of estimation of signifi 
cance to individual sites leads as a main effect 
to a loss of statistical power. For related 
reasons the identification of certain sites as 
"interesting", with reference to response to 
acrylamide in animal experiments, is mostly a 
consequence of the pattern of background 
incidences P? in the animal strain used. 
The authors of the paper1 possess infor 
mation of extreme value in further efforts to 
clarify the carcinogenic potency of acryla 
mide. In view of the importance of this ques 
tion we urge the authors of the paper to con 
tinue their work, particularly with analyses of 
regression on pooled data, primarily for all 
cancers, with and without exclusion of sites 
related to smoking. 
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Marsh et al reply 
Granath et al take issue with our update of a 
cohort of acrylamide workers from three 
United States plants1 claiming that "it exem 
plifies the shortcomings of studies of this type 
to detect moderate influences of specific 
causative factors on cancer mortality or inci 
dence." To support their contention that we 
overlooked a small but "unacceptable" in 
crease in cancer risk, they performed a crude 
quantitative risk assessment. Granath et al 
suggested that we perform a within cohort 
dose-response analysis with all malignant 
neoplasms as the end point as a means of 
attaining greater statistical power. They 
further contend that initial focus on specific 
cancer sites implicated in previous experi 
mental animal studies is mostly a conse 
quence of the pattern of background inci 
dences in the animal strain used. Although 
choosing a generic health outcome such as all 
cancer sites combined will certainly increase 
statistical power, it also greatly reduces the 
ability to evaluate the all important specificity 
of an exposure-response relation. It is un 
likely that even the most potent carcinogenic 
agent will increase the risks of all cancer sites 
to a level that can be detected with epidemio 
logical methods. 
We were fully justified in using cancer site 
specific findings as the focus of our epidemio 
logical investigation. The use of cancer site 
specific findings from experimental animal 
studies to formulate initial testable aetiologi 
cal hypotheses for human studies is an effec 
tive, accepted method commonly used in 
occupational epidemiological research. Ani 
mal studies can be particularly helpful when 
investigators are faced with a paucity of 
extant epidemiological evidence such as in 
the case of acrylamide. This practice does not 
preclude, however, the exploratory investiga 
tion of other non-implicated sites as long as 
the related findings are interpreted in the 
light of their hypothesis generating nature. 
We agree that for many of the initial cancer 
sites examined in our study, the statistical 
power to detect a moderate excess in 
mortality (1.5 to twofold or greater) was low, 
a point considered in the discussion section of 
our paper. However, the power of our study 
to detect a twofold or greater excess in lung 
cancer, the end point of primary concern, at 
the one sided 5% significance level was in the 
excellent range (0.87), as would be the power 
to detect a similar excess of pancreatic cancer 
in a future update of this cohort. 
Granath et al overlook a fundamental 
point?occupational cohort studies of the 
type we used to evaluate cancer mortality 
risks among workers exposed to acrylamide 
are neither designed nor necessarily well 
suited for quantitative risk assessment. Occu 
pational cohort studies are purposely not 
designed to detect small excesses in the range 
of 5%?15% deemed by Granath et al as 
unacceptable. The primary reason for this is 
that excesses of this magnitude could easily 
be due, at least in part, to one or more 
confounding factors. Observational epide 
miological studies usually cannot discrimi 
nate among such small mixed effects, and are 
generally most useful for detecting increases 
in risk that exceed 50%-100% as these are 
unlikely to be due to uncontrolled confound 
ing. Considerations of statistical power not 
withstanding, the fact remains that our study 
is the largest and most comprehensive study 
of exposure to acrylamide conducted to date, 
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and will continue to provide useful epidemio 
logical information through future updates 
and analysis. 
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Dose-response relation between 
acrylamide and pancreatic cancer 
In their 1999 study of workers exposed to 
acrylamide, Marsh et al conducted an SMR 
analysis, and fitted several relative risk 
regression models to the data.1 In each analy 
sis, they found risk of pancreatic cancer 
increased by about twofold for workers in the 
highest cumulative exposure group, but risk 
of pancreatic cancer did not increase monot 
onically with cumulative exposure in any of 
their analyses. Duration of exposure was 
monotonically related and mean intensity 
showed a nearly monotonie relation with risk 
of pancreatic cancer. 
The cut off points Marsh et al chose for the 
cumulative exposure groups are based on 
multiples of current and proposed regulated 
levels of exposure intensity.12 Because these 
cut off points resulted in small numbers of 
expected deaths in the low and intermediate 
exposure groups, 1.08 and 2.74 respectively, 
we have regrouped the data to attempt to 
obtain more stable standardised mortality 
ratios (SMRs). These results are presented in 
table 1 and indicate a monotonie dose 
response pattern with the SMRs increasing 
from 0.80 to 1.31 to 2.26. 
Table 1 Observed deaths, expected deaths, and 
SMRs for cancer of the pancreas, all United 
States workers, 1950-94, local county 
comparisons, two lowest exposure groups combined 
Cumulative 
exposure (mg/m3.y) Obs Exp SMR 95% CI 
<0.001 30 37.50 0.80 0.54 to 1.14 
0.001-0.29 5 3.82 1.31 0.35 to 3.05 
>0.30 9 3.98 2.26 1.03 to 4.29 
In part based on the absence of a pattern of 
monotonically increasing risk with increased 
cumulative exposure, Marsh et al argue that 
"our findings for cancer of the pancreas 
should be interpreted with caution, in the 
context of an exploratory analysis to generate 
hypotheses."1 Nevertheless, given the suffi 
cient evidence in experimental animals for 
the carcinogenicity of acrylamide.3 this study 
plays an important part in the evaluation of 
safety for occupational exposures to acryla 
mide. 
When data are sparse, it is not always clear 
how best to choose cut off points; the group 
ing we have shown results in a finding that is 
more compatible with the findings for 
duration and for intensity of exposure. It 
would be interesting to see if a regrouping of 
the exposure categories alters the results of 
the analyses based on internal comparisons. 
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Amyotrophic lateral sclerosis and 
occupational exposure to 
2,4-dichlorophenoxyacetic acid 
Burns et at report a significant excess of 
deaths due to amyotrophic lateral sclerosis 
(ALS) in a cohort of Dow employees 
potentially exposed to the herbicide 2,4 
dichlorophenoxyacetic (2,4-D), but then 
argue against the plausibility of a causal 
association, concluding that the association 
"is not consistent with previous human or 
animal studies". 
This conclusion and the authors' charac 
terisation of the relevant epidemiological 
studies seem to rely entirely upon the signifi 
cance of the statistics, which downplays the 
importance of their finding. Firstly, the 
authors state that "cohort studies of people 
with exposure to 2,4-D (have not) reported 
increased rates of ALS," citing two studies,2 
3 
both of which have limited power to detect 
the risk of ALS. One of the two studies 
assessed risk in a cohort that was quite young 
with a relatively short follow up,2 and would 
therefore be unlikely to detect an increased 
risk for a disease such as ALS, which has a 
much older median age at onset. Burns et al 
then go on to state that "exposure to 
pesticides and agricultural chemicals have 
shown no significant association in several 
studies" (emphasis added).1 
In each of the three case-control studies 
cited, however, ALS was positively associated 
with pesticides or agricultural chemicals, with 
reported ORs of 1.4,4 2.0,5 and 3.0,6 although 
the associations do not reach significance. 
Finally, Burns et al refer to a case-control 
study,7 which found a significant association 
between ALS and pesticides, but, they 
emphasise, "did not find a significant associ 
ation of exposure to herbicides".1 The associ 
ation between ALS and exposure to herbicide 
was increased, however, and the lack of 
significance reflected, at least in part, small 
numbers. 
None of this is meant to say that the find 
ing of a significant association between ALS 
and 2,4-D is conclusive. The finding is, how 
ever, consistent with several previous studies, 
and instead of being played down, warrants 
serious attention in future studies. 
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Burns replies 
We appreciate the interest taken in our study 
by Freedman. At the heart of the discussion 
are the interpretation of the significance of the 
statistics in our study,1 and the lack of 
significance in others. A critical point in 
valuing causation is the weight of the evidence 
to be placed upon the non-significant increase 
of non-specific exposures found in human 
studies of amyotrophic lateral sclerosis (ALS) 
compared with the weight placed upon con 
trolled animal studies specific to the herbicide 
2,4-dichlorophenoxyacetic acid (2,4-D). 
I agree with Freedman that undue reliance 
upon significance is ill advised. He is correct 
that the case-control studies cited in our 
paper showed increased odds ratios,2"5 but 
there is no evidence that any subjects were 
actually exposed to 2,4-D as the exposures 
were limited to pesticides, agricultural chemi 
cals, and herbicides. The cohort studies 
examined workers who were definitely ex 
posed to 2,4-D and thus provide a more valid 
assessment of risk even though they are less 
powerful than the case-control studies.6 
7 
The 
cohort studies of 2,4-D do not consistently 
show increased risk of ALS. 
The associations found in the case-control 
studies are clearly unsupported by the 
experimental studies that have been con 
ducted on 2,4-D. Environmental causes of 
ALS remain unknown. If future epidemio 
logical studies investigate the neurotoxicity of 
herbicides such as 2,4-D, the researchers 
must improve upon the status quo of 
surrogate exposure information used in case 
control studies or perform further studies of 
the 2,4-D workers. Epidemiologists must 
make a commitment to quality exposure 
assessment of individual pesticides, perhaps 
coupled with biomonitoring, to assess the 
putative health concerns associated with pes 
ticides. 
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Bullying in hospitals 
As victims of bullying and proponents of 
emotional intelligence in the health profes 
sion we read with interest the article on 
workplace bullying.1 
Kavimaki et at did not mention whether 
the responses were anonymous. Identified 
responses may underestimate the incidence 
of bullying in the cohort. Given that previous 
studies (mentioned by the authors in the dis 
cussion) have shown a considerable percent 
age of victims deciding to resign as a result of 
bullying, it is a pity that the article by 
Kivimaki et al did not contain similar data. 
The other two issues that should have been 
included were the duration of the bullying, 
and how many bullies are actually aware that 
they are bullies. These can be answered by 
asking the question: Have you subjected your 
colleagues to such bullying behaviour? 
With doctors and nurses constituting 58% 
of the victims, we wonder whether the 
authors could reanalyse their data to see 
whether there is a higher incidence of 
bullying in the high stress specialties?such as 
adult intensive care and neonatal intensive 
care.2 We would also like to know whether the 
victims in their study were offered any coun 
selling by their institutions, and if so, the 
nature and impact of the counselling. 
Emotional intelligence is defined by the 
five emotional quotients of self awareness of 
feelings, emotional self regulation, self moni 
toring and goal setting, empathy, social skills, 
and communication skills.3 According to 
Goleman, "The rules for work are changing, 
we're being judged by a new yardstick: not 
just how smart we are, or our expertise, but 
also how well we handle ourselves and each 
other."4 Emotional intelligence is considered 
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more important than intelligence quotient 
(IQ) in enabling people to function well in 
society.5 We suggest that emotional intelli 
gence, which can be taught, can be an impor 
tant solution in reducing the incidence of 
bullying in the workplace.6 
TSKOH 
T H H G KOH 
EQ-InSight and Kirwan Hospital, QLD 4814, 
Australia 
Correspondence to: Dr T H H G Koh 
guan_koh@health.qld.gov.au 
1 Kivimaki M, Elovainio M, Vahtera J. Workplace 
bullying and sickness absence in hospital staff. 
Occup Environ Med 2000;57:656-60. 
2 Rosenthal SL, Schmid KD, Black MM. Stress 
and coping in a NICU. Res Nurs Health 
1989;12:257-65. 
3 Goleman D. Emotional intelligence. Why it can 
matter more than IQ. London: Bloomsbury 
Publishing, 1995. 
4 Goleman D. Working with emotional intelligence. 
London: Bloomsbury Publishing, 1998. 
5 Goleman D. What makes a leader? Harvard 
Business Reviews 1998;76:93-102. 
6 Koh TS, Koh THHG. Disruptive doctors: emo 
tion based medicine is as important as evidence 
based medicine. MedJAust 2001;174:313-4. 
